We’re starting off this update with some interesting gold news that actually came last week.

A filing showed last Friday (August 14) that Warren Buffett’s Berkshire Hathaway (NYSE:BRK.A,NYSE:BRK.B) has bought about 21 million shares of Barrick Gold (TSX:ABX,NYSE:GOLD), paying around $560 million for the stake.

This development was surprising for many market watchers because Buffett has made his feelings for gold very clear in the past — and they aren’t positive.


Fear And Debt Push Gold To New Heights In 2020. What's Coming In 2021?

All The Answers You NEED In Our Precious Metals Outlook Report!
Grab Your FREE Report Today!

“If you own one ounce of gold for an eternity, you still own one ounce of gold at its end” — Warren Buffett, Berkshire Hathaway

Speaking about the news, Ian Ball of Abitibi Royalties (TSXV:RZZ) pointed out that it’s not clear if Buffett or someone else at Berkshire Hathaway actually pulled the trigger on the Barrick purchase. But overall he believes it’s positive for gold — in fact, Ian described the unexpected move as “a very large endorsement for gold going forward and for the miners.”

“Here you have one of the most respected investors of all time making their first foray into the gold-mining sector. I thought it was quite encouraging that Berkshire didn’t buy gold, or a gold exchange-traded fund or an index of gold-mining companies. But they’re making a specific bet on one of the world’s top two largest gold miners” — Ian Ball, Abitibi Royalties

Investors seem to share that optimism — shares of Barrick rose about 10 percent on the TSX from last Friday’s close to the end of the day this past Monday (August 17).

Gold itself had its ups and downs this week, but overall a lot of optimism remains about the yellow metal. With that in mind, we asked our Twitter followers if they think gold is an investment that should always be held, or if there are times they would consider selling.

That’s a question that I got some color on during a conversation this week with Will Rhind of GraniteShares — in his opinion, the yellow metal should not be traded and should not be used as a quick way to make money. As it turns out, most of our Twitter poll respondents agree with Will — nearly 65 percent said they buy gold and keep holding it.

“If you’re a seller of gold right now, what are you buying? What is the alternative that is potentially more interesting or more relevant than gold? I think that’s why there’s so much interest in gold and people looking to hold onto gold through these times” — Will Rhind, GraniteShares

We’ll be asking another question on Twitter next week, so make sure to follow us @INN_Resource or follow me @Charlotte_McL to share your thoughts!

Finally, in the cannabis space this week, INN’s Bryan Mc Govern looked at the latest quarterly results in the sector. Matt Hawkins of Entourage Effect Capital told Bryan that from his perspective the industry is in good shape despite the impact of COVID-19.

“We’ve been investing in the industry since 2014, we’ve made 66 investments I believe. There’s never been a better time to invest in the industry” — Matt Hawkins, Entourage Effect Capital

Moving forward, he believes legalization momentum will pick up in the US at both the state and federal level no matter who wins the presidential election in November — Matt said that even conservative-leaning politicians are beginning to realize the revenue opportunities associated with legalization.

Want more YouTube content? Check out our YouTube playlist At Home With INN, which features interviews with experts in the resource space. If there’s someone you’d like to see us interview, please send an email to cmcleod@investingnews.com.

And don’t forget to follow us @INN_Resource for real-time updates! 

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.


BRAND NEW! Take Advantage Of Silver On The Rise Before It's Too Late

Everything You Need To Watch The Dollars Come Pouring In!

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or “the Company”) is pleased to announce that it is partnering with Loud Buddha Trimming to provide processing services to 3rd party growers out of its Daly Facility in Modesto, California.

TransCanna subsidiary Lyfted Farms has signed a Letter of Intent with Loud Buddha Trimming to jointly offer processing services like drying, hand trimming, curing, manicuring, machine trimming, bulk and retail packaging, pre-roll production and packaging, and storage of fresh-frozen biomass for concentrate production.

Keep reading... Show less

 Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”), an established Canadian cannabis and vape retailer, announced today that its wholly-owned subsidiary, Spyder Cannabis Subco Inc. (“Spyder Subco”), has received Retail Store Authorization (“RSA”) from the Alcohol and Gaming Commission of Ontario (“AGCO”) for its proposed cannabis dispensary located at 767 Taunton Road in Oshawa, Ontario.

Furthermore, Spyder Subco has successfully passed a pre-authorization inspection with the AGCO and has now been placed in the queue to receive RSA on its second proposed cannabis dispensary in Niagara Falls, Ontario located at 5719 Victoria Avenue. Both retail premises will continue to operate as vape stores under the 180 Smoke banner name until the Company has finalized its new cannabis dispensary brand and banner name, which is expected to be finalized and announced in the coming weeks. The Company is exploring additional opportunities to convert other 180 Smoke retail locations – leveraging the brand’s current customer base of over 230,000 registered accounts – continuing to build and expand on Spyder’s footprint and presence in Ontario.

Keep reading... Show less

Combination Therapy with Psilocybin plus NAC (N-Acetylcysteine) Is Statistically Significantly Better Than Either Agent Alone or Placebo in a Rodent Model of mTBI and PTSD

Lobe Sciences Ltd. (” Lobe ” or the ” Company “) (CSE: LOBE) (OTC Pink: GTSIF) is pleased to announce interim data from its preclinical research studies, in established rodent models of mild traumatic brain injuryconcussion (“mTBI”) and post-traumatic stress disorder (“PTSD”), using psilocybin plus N-Acetylcysteine (“NAC”). The study is being conducted in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami Miller School of Medicine under the leadership of Michael E. Hoffer M.D., professor of otolaryngology and neurological surgery.

Keep reading... Show less

A recently released cannabis report indicates that new formulations will be needed to satisfy changing consumer styles and demands.

The report from the EY Cannabis in Canada team outlines the rapidly changing cannabis landscape, and explains that the companies out there today need to stay active to be prepared for what’s ahead.

Keep reading... Show less


  • #1 Canadian LP in Global Medical Cannabis; Total Medical Cannabis Net Revenue Rose 9% Compared to Prior Year; Strong Adjusted Gross Margin before FVA of 68%
  • Business Transformation Plan on Track; Reiterates Annual Cost Savings of $60 Million to $80 Million , Providing Clear Pathway to Adjusted EBITDA Profitability
  • Balance Sheet Remains Strong with $440.9 Million of Cash at June 30, 2021 ; Working Capital Improves by $404.3 Million Compared to Prior Year
  • Adjusted EBITDA Loss, Excluding Restructuring Costs, Narrows to $13.9 Million , a $17.6 Million Improvement Compared to Prior Year
  • Total Cannabis Net Revenue, Net of Provisions, of $54.8 Million Compared to $55.2 Million in the Prior Quarter, and $67.5 Million in the Year-Ago Period

 Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the fourth quarter and full year fiscal 2021 ended June 30, 2021 .

Keep reading... Show less